{"id":166559,"date":"2025-01-31T08:49:27","date_gmt":"2025-01-31T13:49:27","guid":{"rendered":"https:\/\/44.250.171.167\/?p=166559"},"modified":"2025-01-31T08:49:27","modified_gmt":"2025-01-31T13:49:27","slug":"sun-pharmaceuticals-industries-ltd-q3fy25-14-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/sun-pharmaceuticals-industries-ltd-q3fy25-14-rise-in-profits\/","title":{"rendered":"Sun Pharmaceuticals Industries Ltd Q3FY25; 14% rise in Profits"},"content":{"rendered":"

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. It is the largest pharmaceutical company in India.<\/p>\n

\nFinancial Results:<\/h2>\n

Sun Pharmaceuticals Industries Ltd reported Revenues for Q3FY25 of \u20b913,675.00 Crores up from \u20b912,381.00 Crore year on year, a rise of 10.45%.<\/p>\n

Total Expenses for Q3FY25 of \u20b910,349.00 Crores up from \u20b99,561.00 Crores year on year, a rise of 8.24%.<\/p>\n

Consolidated Net Profit of \u20b92,913.00 Crores up 13.74% from \u20b92,561.00 Crores in the same quarter of the previous year.<\/p>\n

The Earnings per Share is \u20b912.10, up 15.02% from \u20b910.52 in the same quarter of the previous year.<\/p>\n

 <\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. It is the […]<\/p>\n","protected":false},"author":1863,"featured_media":166560,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[11776,12565,10162],"class_list":["post-166559","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-active-pharmaceutical-ingredients","tag-generic-formulation","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":166509,"url":"https:\/\/alphastreet.com\/india\/torrent-pharmaceuticals-ltd-q3fy25-14-rise-in-profits\/","url_meta":{"origin":166559,"position":0},"title":"Torrent Pharmaceuticals Ltd Q3FY25; 14% rise in Profits","author":"Chirag Gupta","date":"January 24, 2025","format":false,"excerpt":"Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. Financial Results: Torrent Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b92,809.00 Crores up from \u20b92,732.00 Crore year on year, a rise of 2.82%. Total Expenses for Q3FY25 of\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167130,"url":"https:\/\/alphastreet.com\/india\/aurobindo-pharma-ltd-q3fy25-10-fall-in-profits\/","url_meta":{"origin":166559,"position":1},"title":"Aurobindo Pharma Ltd Q3FY25; 10% fall in Profits","author":"Divyansh_Kasana","date":"February 28, 2025","format":false,"excerpt":"Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159) Financial Results: Aurobindo Pharma Ltd reported Revenues for Q3FY25 of \u20b97,979.00 Crores up from \u20b97,352.00 Crore year on year, a rise of 8.53%. Total Expenses for\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/F.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/F.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/F.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/F.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/F.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/F.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167021,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q3fy25-23-fall-in-profits\/","url_meta":{"origin":166559,"position":2},"title":"Alembic Pharmaceuticals Ltd Q3FY25; 23% fall in Profits","author":"Divyansh_Kasana","date":"February 21, 2025","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b91,693.00 Crores up from \u20b91,631.00 Crore year on year, a rise\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165263,"url":"https:\/\/alphastreet.com\/india\/sun-pharmaceuticals-industries-ltd-q2fy25-28-rise-in-profits\/","url_meta":{"origin":166559,"position":3},"title":"Sun Pharmaceuticals Industries Ltd Q2FY25; 28% rise in Profits","author":"Chirag Gupta","date":"October 28, 2024","format":false,"excerpt":"Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/318d2c7a-b0ba-468e-b09a-298d236ded7d.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/318d2c7a-b0ba-468e-b09a-298d236ded7d.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/318d2c7a-b0ba-468e-b09a-298d236ded7d.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/318d2c7a-b0ba-468e-b09a-298d236ded7d.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/318d2c7a-b0ba-468e-b09a-298d236ded7d.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/318d2c7a-b0ba-468e-b09a-298d236ded7d.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164120,"url":"https:\/\/alphastreet.com\/india\/sun-pharmaceuticals-industries-ltd-q1fy25-43-rise-in-profits\/","url_meta":{"origin":166559,"position":4},"title":"Sun Pharmaceuticals Industries Ltd Q1FY25; 43% rise in Profits","author":"Chirag Gupta","date":"August 28, 2024","format":false,"excerpt":"Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-181.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-181.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-181.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-181.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-181.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-181.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":158225,"url":"https:\/\/alphastreet.com\/india\/sun-pharmaceuticals-industries-ltd-q3fy24-17-rise-in-profits\/","url_meta":{"origin":166559,"position":5},"title":"Sun Pharmaceuticals Industries Ltd Q3FY24; 17% rise in Profits","author":"Chirag Gupta","date":"January 31, 2024","format":false,"excerpt":"Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/01\/image-154.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/01\/image-154.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/01\/image-154.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/01\/image-154.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/01\/image-154.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/01\/image-154.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/166559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=166559"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/166559\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/166560"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=166559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=166559"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=166559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}